Masimo Corp (NASDAQ:MASI)

CAPS Rating: 5 out of 5

A global medical technology company that develops, manufactures and markets non-invasive patient monitoring products that improve patient care.

Recs

0
Player Avatar reeshau (47.02) Submitted: 12/22/2011 11:29:54 AM : Outperform Start Price: $18.29 MASI Score: -0.31

I think the selling is overdone here. I am worried that MASI is a one-trick pony, but I am encouraged by their efforts to exclude knockoffs from cutting off their sales of consumables. When your much larger competitor has to license your IP, you are doing well.

Featured Broker Partners


Advertisement